US Dermatology Lead

Job Description

The Position

The Director, Medical Affairs – US OGN Dermatology Lead is a senior, field-facing, and strategy-setting role that sits at the core of Organon's growing dermatology franchise in the United States. This individual will be the primary US medical affairs architect for the dermatology portfolio, anchored by VTAMA® (Tapinarof) cream, 1%. The role reports to the OGN US AVP Medical Affairs Head, and serves as the US medical authority for Organon Dermatology — translating global strategy into US-specific medical plans, supporting the Field Medical Directors Team (FMD), building thought leader relationships with MD, DO and NP-Pas dermatologists, Pediatric dermatologists, and allergists/immunologists, and driving evidence generation and scientific education and communication activities.

Therapeutic Area: Dermatology

Location: Plymouth meeting – PA - (Hybrid – 2 days onsite expected); or Remote with regular HQ travel.

Travel: Up to 30–40% (congresses, field engagement, KOL meetings)

Responsibilities

1. US Medical Affairs Strategy & Execution

• Develop, own, and execute the US Medical Affairs Plan for the Organon Dermatology portfolio, aligned and in collaboration with the Medical Affairs global strategy team, US brand strategy and Organon's corporate objectives.
• Define the US medical narrative and scientific communication platform for our dermatology portfolio, supporting its differentiation as the only Ahr agonist approved for both psoriasis and AD.
• Lead the annual US Medical Affairs planning process including situation analysis, evidence gap assessments, tactical planning, and budget stewardship.
• Identify unmet medical needs and emerging clinical questions in dermatology (AD, psoriasis, comorbidities, pediatric populations) that can be addressed through evidence generation and education.
• Contribute proactively to life cycle management strategy, including potential new indications, formulations, or label expansion opportunities.

2. Support of the US Dermatology Field Medical Team in collaboration with the Field Medical Director (FMD) US Head.

• Provide strategic support and operational support for the US Dermatology FMD Team and any direct reports within the US medical affairs organization.
• Support the setting of FMD KPIs, territory plans, and field medical objectives, ensuring consistent execution of the US Medical Affairs Plan at the field level.
• Foster a culture of scientific excellence, compliance, patient centricity, and continuous development across the dermatology medical team.
• Support talent acquisition, onboarding, and individual development planning for team members.
• Serve as the strategic interface between headquarters medical strategy and field medical execution — synthesizing field insights from FMDs to inform strategy updates.

3. Key Opinion Leader & Stakeholder Engagement

• Identify, engage, and cultivate peer-level scientific relationships with MD, DO and NP-Pas dermatologists, Pediatric dermatologists, and allergists/immunologists, academic leaders, and patient advocacy organizations across the US.
• Lead the planning and execution of US advisory boards, expert panels, and steering committees in alignment with compliance guidelines.
• Represent Organon Dermatology at major national and regional medical congresses (AAD, ACAAI, Society for Pediatric Dermatology, etc.), facilitating data presentations and scientific exchange.
• Build collaborative relationships with guideline committee members and professional societies to ensure appropriate representation of VTAMA data in evolving clinical guidelines.

4. Evidence Generation & Scientific Communications

• In collaboration with the Outcomes research team, develop and oversee the US evidence generation strategy for Organon Dermatology, including real-world evidence (RWE) studies, case reports, observational research, Phase 3b/4 studies, and investigator-initiated studies (IIS).
• Partner with Global Medical Affairs, Outcomes Research, and Clinical Development on study concept development, protocol design, and site selection for US-based studies.
• Support and oversee the US publication plan and ensure timely dissemination of clinical data at congresses and in peer-reviewed journals, in compliance with publication policies.
• Provide medical leadership for US scientific content: medical education materials, congress presentations, medical information responses, and training materials for internal teams.
• Ensure the scientific communication platform reflects the full breadth of product evidence, including Phase 3 pivotal data, pooled analyses, patient-reported outcomes, and pediatric d